技術指標
指標
數值
方向
MACD(12,26,9)
0.422
買入
RSI(14)
72.475
買入
STOCH(KDJ)(9,3,3)
84.876
超買
ATR(14)
2.996
高波動
CCI(14)
137.496
買入
Williams %R
10.014
超買
TRIX(12,20)
1.560
賣出
StochRSI(14)
100.000
超買
搜尋
10X Genomics Inc
TXG添加自選
48.100USD
+1.050+2.23%
收盤 07-23 16:00（美東）報價延遲15分鐘
6.14B總市值
虧損本益比TTM
查看詳細走勢圖
TradingKey 圖表盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
+2.23%
5天
+8.14%
1月
+50.93%
6月
+114.92%
今年開始到現在
+194.91%
1年
+253.16%
關鍵數據
46.820今開
49.500最高
2.99M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
2.34%換手率
47.050昨收
46.820最低
115.00M成交額
虧損本益比靜
7.71市淨率
0.00%股息率 TTM
-2.36%ROA
28.17052週最高
1.00量比
-182.63M淨利潤
127.69M總股本
-0.1738每股盈餘TTM
2.11Beta
-2.98%ROE
8.81052週最低
5.70%振幅
70.39%毛利率
6.14B總市值
8.89回報/風險
4.05%風險率
TradingKey 10X Genomics Inc股票評分
單位: USD 更新時間: 2026-07-23操作建議
10X Genomics Inc當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名25/200位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為38.46。中期看，股價處於上升通道。近一個月，市場表現很強，基本面評分較高，但很強的走勢沒有得到技術面的印證。目前股價在壓力位和支撐位之間，可以做區間波段操作。
10X Genomics Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
10X Genomics Inc亮點
亮點風險
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
分析師目標
基於
16
分析師
買入
評級
38.462
目標均價
-18.51%
漲幅空間
10X Genomics Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
16
分析師
買入
評級
38.462
目標均價
-18.51%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
109
總數
7
中位數
9
平均值
公司名稱
評級分佈
分析師數
10X Genomics Inc
TXG
16
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
亞培
ABT
29
1
2
3
...
22
技術指標
移動平均線
指標
數值
方向
MA5
45.854
買入
MA10
44.979
買入
MA20
41.711
買入
MA50
33.509
買入
MA100
27.509
買入
MA200
22.299
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
10X Genomics Inc簡介
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
公司代碼TXG
公司10X Genomics Inc
CEOSaxonov (Serge Wilson)
網址https://www.10xgenomics.com/
公司股東
相關品種
-1.77%
+8.73%
+0.22%
-1.08%
+7.39%
+3.22%
-2.54%
+0.18%
+1.33%
-2.54%
+0.46%
+1.44%
+1.48%
-0.68%
-0.78%
-0.99%
-0.14%
+4.72%
+3.15%
+0.12%熱門品種
51874.200
+150.200 (+0.29%)
28458.200
-119.800 (-0.42%)
7420.300
+0.400 (+0.01%)
14997.000
-104.000 (-0.69%)
64887.000
-484.000 (-0.74%)
6245.500
+29.800 (+0.48%)
89.503
-2.609 (-2.83%)
321.680
-4.210 (-1.29%)
208.770
-3.290 (-1.55%)
4051.850
+2.480 (+0.06%)
常見問題
10X Genomics Inc(TXG)的當前股價是多少？
10X Genomics Inc(TXG)的當前股價是 48.10。
10X Genomics Inc 的股票代碼是什麼？
10X Genomics Inc的股票代碼是TXG。
10X Genomics Inc股票的52週最高點是多少？
10X Genomics Inc股票的52週最高點是28.17。
10X Genomics Inc股票的52週最低點是多少？
10X Genomics Inc股票的52週最低點是8.81。
10X Genomics Inc的市值是多少？
10X Genomics Inc的市值是6.14B。
現在10X Genomics Inc(TXG)的股票是買入、持有還是賣出？
根據分析師評級，10X Genomics Inc(TXG)的總體評級為買入，目標價格為38.46。
10X Genomics Inc(TXG)股票的每股收益（EPS TTM）是多少
10X Genomics Inc(TXG)股票的每股收益（EPS TTM）是-0.35。